ESMO 2022 curated collection – Skin cancer

Thursday, 17 Nov 2022


Watch again as experts present their highlights in skin cancer from this year’s ESMO meeting and discuss how they may impact practice:

  1. Game Changers in skin cancer
  2. Adjuvant & neoadjuvant therapy in melanoma – feat. SWOG S1801, IMMUNED
  3. Metastatic melanoma updates – feat. TILs in unresectable advanced melanoma
  4. Non-melanoma skin cancer updates – feat. ADMEC-O, neoadjuvant cemiplimab in cSCC

Game Changers in skin cancer

Adjuvant & neoadjuvant therapy in melanoma

Metastatic melanoma updates

Non-melanoma skin cancer updates

These events were supported by unrestricted educational grants and created independently by the limbic in collaboration with the hosts and panels. All studies were selected by the panels and all views expressed are those of the hosts and panels only.

Already a member?

Login to keep reading.

OR
Email me a login link
logo

© 2023 the limbic